Changes to ILDS working practices and plans
The ILDS prioritises the health and safety of our Secretariat team in London, our Board Members, Members and those that we work with around the world.
ILDS STATEMENT ON THE CORONAVIRUS (COVID-19) OUTBREAK – APRIL 2020
The worldwide spread of the coronavirus disease (COVID-19) is a serious public health concern. It is having an impact on the way people around the world live and work.
The International League of Dermatological Societies (ILDS) and the International Foundation for Dermatology (IFD) have been monitoring the situation; following advice from authorities such as the World Health Organization (WHO) and national health authorities and have been taking actions to protect the well-being of those that we work with around the world.
In addition, we recognise that we all have a critical role in supporting efforts to protect individuals and populations around the world and provide specific guidance where possible with regards to those with skin conditions. We are aware that a number of national and regional dermatology societies will be providing their own guidance and we hope to complement that with guidance that can be an additional resource for our members wherever they are based in the world. We will share guidance via email and on our website concerning treatment for patients with skin diseases during the COVID-19 pandemic.
We join with you as leaders of dermatological organisations, health professionals, researchers, patients and patient organisations leaders, policy-makers and other key stakeholders in solidarity towards our common goal of protecting public health at this difficult time. If you have any questions, please do not hesitate to contact the ILDS Secretariat by emailing info@ilds.org.
This statement covers the following areas:
You can read the statement in full here.
ILDS Guidance
ILDS has issued a number of guidance notes which can be found here.
COVID-19 and Skin Registries
There have been increasing reports of dermatologic manifestations of coronavirus (COVID-19). In order to rapidly and centrally collect information from a global network of dermatologists and inform colleagues on the front line combating the virus, the ILDS is actively collaborating with the American Academy of Dermatology (AAD) and other ILDS Member organisations to promote the use of these newly developed registries. These valuable registries are aimed at helping dermatologists around the world rapidly get a better understanding of the consequences of COVID-19 for our patients and their management. three such registries are listed below.
Resources and further information:
The ILDS prioritises the health and safety of our Secretariat team in London, our Board Members, Members and those that we work with around the world.
Supporting efforts to raise awareness of how everyone can protect themselves from COVID-19